Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Aug 01, 2005 (Vol. 25, No. 14)

Sickle Cell Disease

URL:sickle.bwh.harvard.edu/menu_sickle.html
  • Educational value
  • None
Were you aware that sickle cell disease was the first disorder shown to be caused by a defective protein (Pauling and Itano, 1948) and also the first genetic disorder whose molecular basis was known (Ingram and Hunt, 1956)? These are just two tiny tidbits out of a mountain of information available about this fascinating disease available at the Sickle Cell Disease site. The organization is tidy, with a collection of links divided into general interest (very educational), disease management, and research. The latter category only connected to one other piece of information whereas the other two each had about a dozen different links. The writing is superb—clear and informative—and provides an excellent opportunity for the curious to learn more about the disease. An interesting topic, excellently done.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »